Roche Holding AG (RHHBY)

PNK: RHHBY · Real-Time Price · USD

39.72

-1.05 (-2.58%)

At close: May 01, 2025, 3:59 PM

-2.58% (1D)

Bid	39.32
Market Cap	255.69B
Revenue (ttm)	89.47B
Net Income (ttm)	17.76B
EPS (ttm)	1.57
PE Ratio (ttm)	25.3
Forward PE	n/a
Analyst	n/a

Ask	39.72
Volume	273,960
Avg. Volume (20D)	3,435,652
Open	41.00
Previous Close	40.77
Day's Range	39.33 - 41.10
52-Week Range	29.20 - 44.31
Beta	0.22

About RHHBY

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neu...

[Read more]

Industry Drug Manufacturers - General

Sector Healthcare

IPO Date Aug 20, 2003

Employees 103,249

Stock Exchange PNK

Ticker Symbol RHHBY

Website https://www.roche.com

Full Company Profile

Why Price Moved

7 months ago

-5.89%

Roche shares are trading lower following weight lo... Unlock content with Pro Subscription

News

8 hours ago · zacks.com

Roche Holding AG (RHHBY) is a Great Momentum Stock: Should You Buy?

Does Roche Holding AG (RHHBY) have what it takes to be a top stock pick for momentum investors? Let's find out.

23 hours ago · zacks.com

Is Roche Holding (RHHBY) Stock Outpacing Its Medical Peers This Year?

Here is how Roche Holding AG (RHHBY) and argenex SE (ARGX) have performed compared to their sector so far this year.

2 days ago · youtube.com

David Roche: U.S. dollar is likely to drop another 15-20%, causing a sell-off of treasuries

David Roche of Quantum Strategy says a weaker dollar will drive 10-year yields to 5.5%, which will threaten the dollar's dominance. He says the Fed can do little to prevent this selling of treasuries.

3 days ago · marketbeat.com

3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.

Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins. Many huge corporations have announced plans to invest billions in U.S. manuf...

5 days ago · seekingalpha.com

Roche: Key Products Stall, Obesity Pipeline Takes Shape

Roche's Q1 revenues beat Street consensus, but key growth products underperformed, making the beat less appealing. Mid-sized products like Phesgo, Xolair, and Polivy drove the revenue beat, compensati...

6 days ago · businesswire.com

New England Journal of Medicine Publishes Phase III Data Showing Single-dose Xofluza Significantly Reduces Influenza Virus Transmission

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the New England Journal of Medicine (NEJM) has published a detail...

1 week ago · seekingalpha.com

Roche Holding AG (RHHBY) Q1 2025 Sales/ Trading Statement Call Transcript

Roche Holding AG (OTCQX:RHHBY) Q1 2025 Sales/ Trading Statement Call April 24, 2025 8:00 AM ET Company Participants Thomas Schinecker - Chief Executive Officer Alan Hippe - Chief Financial & Informati...

1 week ago · zacks.com

Roche's Q1 Sales Increase Y/Y on Solid Performance of Key Drugs

RHHBY records impressive first-quarter 2025 performance on the back of strong demand for key drugs. The company confirms 2025 guidance.

1 week ago · proactiveinvestors.co.uk

Roche CEO says his team is in touch with White House directly over tariffs

Roche is seeking relief from US import tariffs, arguing that its exports of American-made drugs and diagnostics offset the value of products it ships into the country. Reporting a conference call with...

1 week ago · reuters.com

Roche seeks US tariff relief in direct talks with Trump administration

Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products it ships into the United States are offset by its exports of U.S.-made drugs...

Load More News